Best practice guidelines for molecular analysis in spinal muscular atrophy

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• Spinal muscular atrophies (SMAs) are frequent autosomal recessive disorders with a prevalence of ~1/10,000.
• Patients present with varying severity, classified into SMA types I-IV.
• The 5q13 genomic region, containing the survival motor neuron 1 (SMN1) gene, is complex and unstable, complicating molecular diagnosis.

Purpose of the Study:

• To describe guidelines for molecular analysis in SMA diagnosis, carrier detection, and prenatal testing.
• To address challenges in SMA molecular diagnosis, including SMN1 gene complexity and SMN-like phenotypes.
• To provide an overview of materials and resources for SMA molecular diagnostics.

Main Methods:

• Review of molecular diagnostic approaches for SMA, including direct and indirect methods.
• Analysis of the SMN gene structure, including SMN1 and SMN2 gene copies and their homology.
• Discussion of challenges such as high de novo mutation frequency and SMN-like phenotypes.

Main Results:

• Guidelines for molecular analysis in diagnostic, carrier, and prenatal testing applications are detailed.
• The high homology between SMN1 and SMN2 genes, with only five base-pair differences, complicates differentiation.
• The study acknowledges the existence of SMA-like phenotypes not caused by SMN1 mutations and asymptomatic carriers.

Conclusions:

• Accurate molecular diagnosis of SMA is crucial despite genomic complexities.
• Standardized guidelines and resources are essential for effective SMA genetic testing.
• Further understanding of SMN gene variations and related phenotypes is needed for comprehensive diagnosis.